Literature DB >> 2805068

The human estrogen receptor has two independent nonacidic transcriptional activation functions.

L Tora1, J White, C Brou, D Tasset, N Webster, E Scheer, P Chambon.   

Abstract

We have previously reported the presence of a hormone-inducible transcriptional activation function (TAF-2) within the region of the estrogen receptor (ER) that contains the hormone binding domain. We show here that the N-terminal A/B region of the ER contains an independent constitutive activation function (TAF-1) that exhibits cell type specificity since it activates transcription efficiently in chicken embryo fibroblasts, but only poorly in HeLa cells. By analyzing the ability of TAF-1, TAF-2, and the GAL4 and VP16 acidic activating domains (AADs) to homosynergize and heterosynergize with one another and with the factor binding to the upstream element (UE) of the adenovirus 2 major late promoter, we show that the activation properties of TAF-1 and TAF-2 are different and distinct from those of AADs, in agreement with the absence of acidic amino acid stretches in TAF-1 and TAF-2.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2805068     DOI: 10.1016/0092-8674(89)90031-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  277 in total

1.  Molecular determinants of the estrogen receptor-coactivator interface.

Authors:  H Y Mak; S Hoare; P M Henttu; M G Parker
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  Domain structure of the NRIF3 family of coregulators suggests potential dual roles in transcriptional regulation.

Authors:  D Li; F Wang; H H Samuels
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

3.  Epidermal growth factor receptor and tyrosine phosphorylation of estrogen receptor.

Authors:  D C Márquez; J Lee; T Lin; R J Pietras
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

4.  Ligand-independent activation of oestrogen receptor alpha by caveolin-1.

Authors:  A Schlegel; C Wang; R G Pestell; M P Lisanti
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

5.  ER beta inhibits proliferation and invasion of breast cancer cells.

Authors:  G Lazennec; D Bresson; A Lucas; C Chauveau; F Vignon
Journal:  Endocrinology       Date:  2001-09       Impact factor: 4.736

6.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription.

Authors:  G J Kato; J Barrett; M Villa-Garcia; C V Dang
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

Review 7.  Evolutionary origins of the estrogen signaling system: insights from amphioxus.

Authors:  G V Callard; A M Tarrant; A Novillo; P Yacci; L Ciaccia; S Vajda; G-Y Chuang; D Kozakov; S R Greytak; S Sawyer; C Hoover; K A Cotter
Journal:  J Steroid Biochem Mol Biol       Date:  2011-04-14       Impact factor: 4.292

8.  Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RAR gamma degradation and transactivation.

Authors:  Maurizio Giannì; Annie Bauer; Enrico Garattini; Pierre Chambon; Cécile Rochette-Egly
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

9.  Ligand dependence of estrogen receptor induced changes in chromatin structure.

Authors:  D M Gilbert; R Losson; P Chambon
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

10.  Antioxidant: a new role for RU-486 and related compounds.

Authors:  S Parthasarathy; A J Morales; A A Murphy
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.